Litcius/Paper detail

A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood–brain Barrier in the Treatment of Patients With Philadelphia Chromosome–positive Acute Lymphoblastic Leukemia

Xiaoyuan Gong, Le Li, Hui Wei, Bingcheng Liu, Chunlin Zhou, Guangji Zhang, Kaiqi Liu, Dong Lin, Benfa Gong, Shuning Wei, Yan Li, Yingchang Mi, Ying Wang, Jianxiang Wang

2021Clinical Therapeutics27 citationsDOI

Topics & Concepts

MedicineDasatinibLymphoblastic LeukemiaPhiladelphia chromosomeBlood–brain barrierInternal medicineOncologyLeukemiaPharmacologyImatinibGeneticsChromosomal translocationGeneMyeloid leukemiaCentral nervous systemBiologyChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research